|

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease

RECRUITINGN/ASponsored by Magnes AG
Actively Recruiting
PhaseN/A
SponsorMagnes AG
Started2026-01-10
Est. completion2026-05
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare gait speed, cadence, stride length, usability, and safety. It is a low-risk pilot study meant to generate first evidence for future research.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion criteria:

* A medically confirmed diagnosis of Parkinson's disease on the physiotherapy prescription.
* Stable medication for at least four weeks (no change in dopaminergic therapy).
* The ability to walk at least 200 metres without stopping.
* Minimum age: 18 years
* Sufficient knowledge of German to understand the study information and complete the questionnaires.
* Written informed consent form

Exclusion criteria:

* Atypical or secondary Parkinsonism
* Sensory disturbances in the feet (e.g. polyneuropathy).
* Other neurological, orthopaedic or internal medical conditions that significantly affect walking
* Cognitive impairments that interfere with understanding the study information or following instructions

Conditions2

Parkinson's DiseaseParkinson's Disease (PD)

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.